organization · Reporting owner
Medmira Capital Ltd.
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HCW Biologics Inc.HCWB · Entity 8172 | 10% owner | September 15, 2021 | September 17, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HCW Biologics Inc.
Report date September 15, 2021 · Filed September 17, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2021-09-15 transaction · row 1
1 source rowRow 1 · 2021-09-15 · Other · Disposed 3,587,659 · Balance 0 F1: Pro-rata in-kind stock distribution to its members or member's designee for no consideration. |
Filing footnotes · ownership attribution and instrument terms
F1: Pro-rata in-kind stock distribution to its members or member's designee for no consideration.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 15, 2021 Filed Sep 17, 2021 17:12 UTC | HCW Biologics Inc. HCWB · Entity 8172 | OtherCommon Stock | 3,587,659 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-056677 · doc4.xml · nonDerivative · entry 1 Medmira Capital Ltd. · CIK 0001872543 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Pro-rata in-kind stock distribution to its members or member's designee for no consideration. Read SEC document |
| July 22, 2021 Filed Jul 23, 2021 19:32 UTC | HCW Biologics Inc. HCWB · Entity 8172 | ConversionSeries C Redeemable Preferred Stock · Derivative | 730,519 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-048086 · doc4.xml · derivative · entry 4 Medmira Capital Ltd. · CIK 0001872543 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 730,519 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of the Series C Redeemable Convertible Preferred Stock automatically converted into one share of the Issuer's Common Stock, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date. F2 · derivative.exercise_date: Each share of the Series C Redeemable Convertible Preferred Stock automatically converted into one share of the Issuer's Common Stock, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date. F2 · derivative.expiration_date: Each share of the Series C Redeemable Convertible Preferred Stock automatically converted into one share of the Issuer's Common Stock, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date. Read SEC document |
| July 22, 2021 Filed Jul 23, 2021 19:32 UTC | HCW Biologics Inc. HCWB · Entity 8172 | ConversionSeries B Redeemable Preferred Stock · Derivative | 2,857,142 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-048086 · doc4.xml · derivative · entry 3 Medmira Capital Ltd. · CIK 0001872543 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,857,142 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of the Series B Redeemable Convertible Preferred Stock automatically converted into one share of the Issuer's Common Stock, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date. F1 · derivative.exercise_date: Each share of the Series B Redeemable Convertible Preferred Stock automatically converted into one share of the Issuer's Common Stock, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date. F1 · derivative.expiration_date: Each share of the Series B Redeemable Convertible Preferred Stock automatically converted into one share of the Issuer's Common Stock, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date. Read SEC document |
| July 22, 2021 Filed Jul 23, 2021 19:32 UTC | HCW Biologics Inc. HCWB · Entity 8172 | ConversionCommon Stock | 730,519 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-048086 · doc4.xml · nonDerivative · entry 2 Medmira Capital Ltd. · CIK 0001872543 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,587,661 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 22, 2021 Filed Jul 23, 2021 19:32 UTC | HCW Biologics Inc. HCWB · Entity 8172 | ConversionCommon Stock | 2,857,142 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-048086 · doc4.xml · nonDerivative · entry 1 Medmira Capital Ltd. · CIK 0001872543 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,857,142 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.